Drug Profile
DWJ 1341
Alternative Names: DWJ-1341Latest Information Update: 28 Feb 2018
Price :
$50
*
At a glance
- Originator Daewoong Pharmaceutical
- Class Analgesics
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Pain
Most Recent Events
- 28 Feb 2018 No recent reports of development identified for phase-I development in Pain in South Korea